Overview

Different Volumes of Articaine for Inferior Alveolar Nerve Block in Irreversible Pulpitis

Status:
Recruiting
Trial end date:
2023-10-31
Target enrollment:
Participant gender:
Summary
This is a randomized clinical trial comparing the anaesthetic efficacy of 1.8 and 3.6 mL of Articaine for inferior alveolar nerve block when treating mandibular molars with Irreversible Pulpitis
Phase:
Phase 2
Details
Lead Sponsor:
Armed Forces Institute of Dentistry, Pakistan
Treatments:
Carticaine
Epinephrine